As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting efforts took hold and sales ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
Do you have questions surrounding COVID-19, the vaccine and impacts on our communities? ABC13 is committed to finding answers and connecting you with resources. Man deliberately gets 217 Covid ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed by Pfizer and Moderna which target newer variants of the SARS-CoV-2 virus, it was announced ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
Mar. 15, 2024 — Researchers identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- The benefits of combination vaccines may seem ...
‘My hope is that someday, Harvard will find its way back to academic freedom and independence.’ The cardiac risk to younger people must be balanced against the extremely low risk this group ...
NYC VACCINE TRACKER: Where you can get the COVID-19 shot in New York City Trying to find a vaccine available to you? This searchable tool helps you find locations with available doses in New York ...